IP Library Granted Patent US 12,354,497
Granted Patent B2
US 12,354,497 · App. 18/373,107 · Granted Jul 8, 2025

Systems and methods for visualizing effects

Inventors: Maury D. Cole (San Diego, CA); Kim N. Wilcox (Ontario, CA)
Assignee: KMM Technology, Incorporated
G09B23/34G06F3/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,354,497
App. No.
18/373,107
Granted
Jul 8, 2025
Kind
B2
Abstract

The present disclosure provides systems and methods for visualizing various effects of consuming (e.g., inhaling) one or more substances, especially on the human brain and lungs.

Claims (25)

1. A system, comprising:

a model of an organ or portion thereof comprising an inlet port and an outlet port;

a supply system for supplying a vaporized test liquid into the model via the inlet port;

a first supply path between the supply system and the inlet port, the first supply path comprising a hose; and

wherein the model comprises an indicator configured to emit an indication based on a presence of the vaporized test liquid in the model.

2. The system of claim 1 , wherein the supply system comprises a vaporizer, a controller, and a liter per minute gauge.

3. The system of claim 2 , further comprising a second supply path and a vacuum system, wherein the second supply path extends between the outlet port and the vacuum system.

4. The system of claim 3 , wherein the vacuum system comprises a vacuum pump and a HEPA filter.

5. The system of claim 1 , wherein the indication is visual, and comprises a condensation.

6. The system of claim 1 , wherein the indication is visual, and comprises at least one of a color, a pattern and a brightness of a light.

7. The system of claim 4 , wherein the vacuum pump is configured to draw ambient air into the model via the liter per minute gauge.

8. The system of claim 7 , wherein the vacuum pump is further configured to draw the vaporized test liquid from the vaporizer into the model when the vaporizer is on.

9. The system of claim 1 , wherein the indication comprises at least one of a sound, a smell, and a visual indication.

10. A system of claim 1 , further comprising:

a first input device communicatively coupled to the supply system.

11. The system of claim 10 , further comprising a second model of a second organ, wherein the supply system is coupled to the second model of the second organ.

12. The system of claim 11 , wherein the second model comprises a second indicator configured to emit an indication based on a user input into the first input device that corresponds to an amount or type of vaporized test liquid entering the first model.

13. The system of claim 11 , wherein the second model comprises a second indicator configured to emit an indication based on a user input into the first input device that corresponds to an amount or type of vaporized test liquid entering the second model.

14. The system of claim 10 , further comprising a computing device programmed with a curriculum relating to use of the first input device, the supply system, and the first model.

15. The system of claim 14 , wherein a display associated with at least one of the input device and the computing device is configured to display a second indication based on a user input into the first input device that corresponds to an amount or type of vaporized test liquid entering the first model, and wherein the second indication is a modified image of a user's face.

16. The system of claim 13 , wherein the first organ is a lung, and the second organ is a brain.

17. The system of claim 1 , wherein a test liquid that that is vaporized to form the vaporized test liquid comprises at least one of nicotine, a methamphetamine, and a tetrahydrocannabidiol.

18. The system of claim 1 , wherein the vaporized test liquid is representative of a drug but does not comprise the drug.

19. The system of claim 1 , further comprising a second supply path and a vacuum system, wherein the second supply path extends between the outlet port and the vacuum system.

20. The system of claim 19 , wherein the vacuum system is configured to draw ambient air into the model via the supply system.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2024
From: COLE, MAURY D.; WILCOX, KIM N.
To: KMM TECHNOLOGY, INCORPORATED
Reel/Frame 067962/0865 →
Continuity (3)
Continuation 17061243 · Oct 1, 2020
Provisional Application 62909634 · Oct 2, 2019
Related Publication 20240029588A1 · Jan 25, 2024
References Cited (26)
US 7252050B2 · Cole · 2007 [cited by applicant]
US 9342996B2 · King · 2016 [cited by examiner]
US 11062626B2 · McHale · 2021 [cited by examiner]
US 11250383B2 · Sharma et al. · 2022 [cited by applicant]
US 20020098272A1 · Silver · 2002 [cited by applicant]
US 20070059454A1 · Slimak · 2007 [cited by applicant]
US 20070260313A1 · Sidler · 2007 [cited by applicant]
US 20110144658A1 · Wenderow · 2011 [cited by examiner]
US 20160314716A1 · Grubbs · 2016 [cited by examiner]
US 20160332388A1 · Park et al. · 2016 [cited by applicant]
US 20160374618A1 · Giovangrandi · 2016 [cited by applicant]
US 20180018904A1 · Okayama · 2018 [cited by examiner]
US 20180108276A1 · Ishiyama · 2018 [cited by examiner]
US 20180228990A1 · Cole · 2018 [cited by applicant]
US 20200005901A1 · Cohen · 2020 [cited by examiner]
US 20200237225A1 · Addison et al. · 2020 [cited by applicant]
US 20200253560A1 · De Haan · 2020 [cited by applicant]
US 20200365057A1 · Fernandez · 2020 [cited by examiner]
US 20210235992A1 · Addison · 2021 [cited by applicant]
US 20210350723A1 · Pirlot · 2021 [cited by examiner]
US 20220046997A1 · Atkins et al. · 2022 [cited by applicant]
KR 20160047238A · 2016 [cited by applicant]
WO 2017049380A1 · 2017 [cited by applicant]
Xi et al., “Visualization of local deposition of nebulized aerosols in a human upper respiratory tract model,” Journal of The Visualization, vol. 21, No. 2, Nov. 27, 2017, pp. 225-237. [cited by applicant]
Cheung et al., “An externally and internally deformable, programmable lung motion phantom,” Medical Physics, Apr. 24, 2015, vol. 42, No. 5, pp. 2585-2593. [cited by applicant]
International Preliminary Report on Patentability for PCT/US2020/054019 mailed on Apr. 14, 2022, 8 pages. [cited by applicant]